IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer
Dool, C. J., Mashhedi, H., Zakikhani, M., David, S., Zhao, Y., Birman, E., Carboni, J. M., Gottardis, M., Blouin, M.-J., Pollak, M.Volume:
18
Language:
english
Journal:
Endocrine Related Cancer
DOI:
10.1530/ERC-11-0136
Date:
November, 2011
File:
PDF, 219 KB
english, 2011